News
The German pharma will license a KRAS G12D inhibitor from Kumquat Biosciences. Elsewhere, a Biohaven OCD drug missed its ...
Labradors are often ranked as one of the best dogs to get, as they're relatively easy to take care of if you're a first time ...
East Baton Rouge Parish's Office of Community Development mismanaged millions of dollars in housing money and is under ...
Strong health traits have edged a new young Holstein sire into top place in the latest genomic index ranking, published today ...
Dayna Altman is a baker, speaker, author, and mental health advocate, stirring up conversations to support healing, vulnerability, and recovery. She spoke on a podcast, Keep Calm and Mental Health ...
The WAFB I-TEAM has confirmed from multiple sources that state and federal investigators have been working together for ...
Whether you’re accident-prone, somehow always tracking dirt and sand, or live in a home with kids and pets, a handheld vacuum ...
A vet has shared four things people should be aware of before getting a Labrador, as they claim most people don't know ...
Veterinarian Amir Anwary has shared his top tips for people looking to get a labrador, including what to think about and how ...
I set out from my parish determined to get arrested at the demonstration in Parliament Square. I was nervous, with ...
5h
TipRanks on MSNBiohaven price target lowered to $52 from $57 at BairdBaird lowered the firm’s price target on Biohaven (BHVN) to $52 from $57 and keeps an Outperform rating on the shares. The firm updated its model ...
5h
TipRanks on MSNBiohaven price target lowered to $49 from $50 at BofABofA lowered the firm’s price target on Biohaven (BHVN) to $49 from $50 and keeps a Buy rating on the shares. The Q2 update “offered some minor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results